about
A score to predict short-term risk of COPD exacerbations (SCOPEX).Impact of thrombus aspiration during ST-Elevation Myocardial Infarction: a six month composite endpoint and risk of stroke analyses of the TASTE trial.Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease.Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease.Oxygen Therapy in Suspected Acute Myocardial Infarction.DETermination of the role of OXygen in suspected Acute Myocardial Infarction trial.Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease.
P50
Q30619543-4913AD74-8FEC-4A22-B7B2-60E54F63753AQ35977146-0D19952B-DBFD-42AD-9CC4-9A1EC6CAFCE5Q37076194-66E23766-5817-42B6-A6B8-09254403E327Q38385145-FA236711-7BDB-4B10-8EA9-1091C873389FQ38606887-276AB21D-BEC8-48D5-B15F-CD37A0D77285Q39243421-CE72D559-98D6-424B-9EEC-0C204D98284EQ40087064-BD127740-A2A1-4B43-BB65-045D9DF5C09F
P50
description
onderzoeker
@nl
name
Ollie Östlund
@ast
Ollie Östlund
@en
Ollie Östlund
@nl
Ollie Östlund
@sl
type
label
Ollie Östlund
@ast
Ollie Östlund
@en
Ollie Östlund
@nl
Ollie Östlund
@sl
prefLabel
Ollie Östlund
@ast
Ollie Östlund
@en
Ollie Östlund
@nl
Ollie Östlund
@sl